ArticleNature medicine2025
The People-First Liver Charter.
Abstract read
In one paragraph
Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- EASL position paper on palliative care in advanced chronic liver disease.JHEP reports : innovation in hepatology · 2026Guideline
- The liver in diabetes: current state and future perspectives.Diabetologia · 2026Review
- Socioeconomic Inequalities in Receipt of Curative-Intent Treatment and Survival After Surveillance-Detected Hepatocellular Carcinoma: A Nationwide Cohort Study.Alimentary pharmacology & therapeutics · 2026Article
- Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining.Hepatology communications · 2026Article
- Lifespan approaches for the prevention and management of steatotic liver disease.Nature reviews. Gastroenterology & hepatology · 2026Review
- A people-first, systems-oriented approach to liver disease in HIV infection.Nature reviews. Gastroenterology & hepatology · 2026Article
- Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.The Lancet regional health. Europe · 2026Review
- Ending the Chronic Liver Disease Public Health Threat: Systemic Challenges Through the Patient Lens.The Lancet regional health. Europe · 2026Article
- Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease.Nature reviews. Gastroenterology & hepatology · 2026Review
- Name MASLD/MASH - and act on it.Hepatology communications · 2026Article
- Name MASLD/MASH - and act on it.JHEP reports : innovation in hepatology · 2026Article
- Multisystem burden in cirrhosis: lessons from a marginalised population.The Lancet regional health. Western Pacific · 2025Article
- Global Think-tank on Steatotic Liver Disease 2025 meeting.The Lancet regional health. Europe · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors.
Jeffrey V LazarusCity University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. jeffrey.lazarus@sph.cuny.edu.ORCID http://orcid.org/0000-0001-9618-2299
Dana Ivancovsky WajcmanBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Silvana PannainSection of Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, IL, USA.
Paul N BrennanDivision of Molecular and Clinical Medicine, University of Dundee, Dundee, Scotland, UK.ORCID http://orcid.org/0000-0001-8368-1478
Melina I ManolasDivision of Endocrinology, Montefiore-Einstein Medical Center, New York, NY, USA.
Peter JepsenDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Carla TreloarCentre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
Anish K AroraFaculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Philippa C MatthewsThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-4036-4269
Camila A PicchioBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Trenton M WhiteCity University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.
Jason GrebelyThe Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Juan VazDepartment of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7232-8000
Hannes HagströmDepartment of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Kenneth H RabinCity University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.
Scott IsaacsDepartment of Medicine, Emory University School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0009-0007-3908-3244
Rogério T RibeiroDepartment of Research and Innovation, APDP-Diabetes Portugal, Lisbon, Portugal.
Michael RodenDepartment of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, University Hospital, Düsseldorf, Germany.ORCID http://orcid.org/0000-0001-8200-6382
Michael BetelFatty Liver Alliance, Toronto, Ontario, Canada.
José WillemseDutch Liver Patients Association, Hoogland, the Netherlands.
Luis Antonio DíazMASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA.
Alina M AllenDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Naim AlkhouriSteatotic Liver Disease Program, Arizona Liver Health, Phoenix, AZ, USA.
Jörn M SchattenbergDepartment of Internal Medicine II, Saarland University Medical Centre, Homburg, Germany.ORCID http://orcid.org/0000-0002-4224-4703
Dídac MauricioDepartment of Endocrinology & Nutrition, CIBERDEM, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2868-0250
Mary E RinellaDivision of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-0620-9705
Elisa PoseLiver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Emmanuel A TsochatzisUCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.ORCID http://orcid.org/0000-0001-5069-2461
Michael NinburgHepatitis Education Project, Seattle, WA, USA.
Kenneth CusiDivision of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-8629-418X
William AlazawiBarts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK.
Ajay DusejaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Gema FrühbeckDepartment of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.ORCID http://orcid.org/0000-0002-8305-7154
Holly LoftonDepartment of Surgery, Bariatric Division, Department of Internal Medicine, NYU Grossman School of Medicine, New York, NY, USA.
Priya JaisinghaniDivision of Endocrinology, Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA.
Fasiha KanwalSection of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Gamal ShihaEuropean Liver Patients' Association (ELPA), Brussels, Belgium.
Shira Zelber-SagiSchool of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
Larry HoldenGlobal Liver Institute, Washington, DC, USA.
Marcela Villota-RivasBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.ORCID http://orcid.org/0000-0002-7332-735X
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
40473951What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.